Price (delayed)
$32.75
Market cap
$5.21B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.99
Enterprise value
$6.36B
Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza , Tegsedi , and
There are no recent dividends present for IONS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.